PHARMACOKINETICS OF INTRAVENOUS, INTRAPERITONEAL, AND SUBCUTANEOUS RECOMBINANT ERYTHROPOIETIN IN PATIENTS ON CAPD - A RATIONALE FOR TREATMENT

被引：0
|
作者：
MACDOUGALL, IC
ROBERTS, DE
NEUBERT, P
DHARMASENA, AD
COLES, GA
WILLIAMS, JD
机构：
来源：
ERYTHROPOIETIN : FROM MOLECULAR STRUCTURE TO CLINICAL APPLICATION | 1989年 / 76卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：112 / 121
页数：10
相关论文
共 50 条
  • [1] COMPARATIVE PHARMACOKINETICS OF RECOMBINANT ERYTHROPOIETIN ADMINISTERED BY THE INTRAVENOUS, SUBCUTANEOUS, AND INTRAPERITONEAL ROUTES IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD) PATIENTS
    BOELAERT, JR
    SCHURGERS, ML
    MATTHYS, EG
    BELPAIRE, FM
    DANEELS, RF
    DECRE, MJ
    BOGAERT, MG
    PERITONEAL DIALYSIS INTERNATIONAL, 1989, 9 (02): : 95 - 98
  • [2] THE PHARMACOKINETICS OF RECOMBINANT ERYTHROPOIETIN IN CAPD PATIENTS
    MACDOUGALL, IC
    COLES, GA
    WILLIAMS, JD
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 273 - 273
  • [3] SUBCUTANEOUS RECOMBINANT ERYTHROPOIETIN IN THE TREATMENT OF RENAL ANEMIA IN CAPD PATIENTS
    MACDOUGALL, IC
    CAVILL, I
    DAVIES, ME
    HUTTON, RD
    COLES, GA
    WILLIAMS, JD
    ERYTHROPOIETIN : FROM MOLECULAR STRUCTURE TO CLINICAL APPLICATION, 1989, 76 : 219 - 226
  • [4] PHARMACOKINETICS OF INTRAPERITONEAL, INTRAVENOUS, AND SUBCUTANEOUS RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    ATESHKADI, A
    JOHNSON, CA
    OXTON, LL
    HAMMOND, TG
    BOHENEK, WS
    ZIMMERMAN, SW
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (06) : 635 - 642
  • [5] INTRAVENOUS VERSUS SUBCUTANEOUS ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS ON HEMODIALYSIS AND CAPD
    EIDEMAK, I
    FRIEDBERG, MO
    LADEFOGED, SD
    LOKKEGAARD, H
    PEDERSEN, E
    SKIELBOE, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (06) : 526 - 529
  • [6] PHARMACOKINETICS OF INTRAVENOUS AND INTRAPERITONEAL CEFOTAXIME IN PATIENTS UNDERGOING CAPD
    MATOUSOVIC, K
    MORAVEK, J
    VITKO, S
    PRAT, V
    HORCICKOVA, M
    PERITONEAL DIALYSIS BULLETIN, 1985, 5 (01): : 33 - 35
  • [7] INTRAVENOUS VERSUS SUBCUTANEOUS APPLICATION OF ERYTHROPOIETIN IN PATIENTS ON RDT AND CAPD
    STOCKENHUBER, F
    LOIBL, U
    JAHN, C
    MANKER, W
    MEISSL, F
    DRUML, W
    BALCKE, P
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 379 - 379
  • [8] SUBCUTANEOUS (SC) TREATMENT OF PATIENTS WITH CAPD WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHU-EPO)
    MIGUELEZ, MC
    GUERRERO, A
    DEPAULA, A
    RODRIGO, A
    MOLINA, A
    KIDNEY INTERNATIONAL, 1990, 37 (06) : 1592 - 1592
  • [9] SINGLE DOSE PHARMACOKINETICS OF RECOMBINANT HUMAN ERYTHROPOIETIN (RH EPO) COMPARING INTRAVENOUS (IV), SUBCUTANEOUS (SC) AND INTRAPERITONEAL (IP) ADMINISTRATION IN IPD PATIENTS
    KROMER, G
    SOLF, A
    EHMER, B
    KAUFMANN, B
    QUELLHORST, E
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 331 - 331
  • [10] PHARMACOKINETICS AND PHARMACODYNAMICS OF SUBCUTANEOUS AND INTRAPERITONEAL ADMINISTRATION OF RECOMBINANT HUMAN ERYTHROPOIETIN IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    LUI, SF
    CHUNG, WWM
    LEUNG, CB
    CHAN, K
    LAI, KN
    CLINICAL NEPHROLOGY, 1990, 33 (01) : 47 - 51
12345